Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Mar;91(3):1019–1027. doi: 10.1172/JCI116258

Transforming growth factor beta 2 in epithelial differentiation of developing teeth and odontogenic tumors.

K Heikinheimo 1, R P Happonen 1, P J Miettinen 1, O Ritvos 1
PMCID: PMC288055  PMID: 8450031

Abstract

Dysregulation of TGF beta 2, a modulator of cell growth and differentiation, can result in uncontrolled growth and tumor formation. Our comparative studies on the expression of TGF beta 2 mRNA and protein indicate that TGF beta 2 may primarily be a regulator of epithelial differentiation during tooth development (between 13 and 20 gestational wk) and tumorigenesis of odontogenic neoplasms. A paracrine mode of action for TGF beta 2 in early human tooth germ (cap/early bell stage) is suggested by location of mRNA in the mesenchyme surrounding the tooth germ, whereas protein is found in the epithelial dental lamina and enamel organ. During the late bell stage, TGF beta 2 gene expression shifted from the mesenchyme to the odontogenic epithelium and was colocalized with protein, suggesting an autocrine role for the terminal differentiation of ameloblasts. In odontogenic tumors of epithelial origin (ameloblastomas) and epithelial-ectomesencymal origin (ameloblastic fibromas), TGF beta 2 mRNA was mostly located in the mesenchymal tumor component and protein in the epithelial tumor component. Odontogenic ectomesenchymal tumors (myxomas) were not associated with TGF beta 2 mRNA and protein expression. The results imply that TGF beta 2 may play an important role in epithelial-mesenchymal interactions in human tooth morphogenesis and development of odontogenic tumors.

Full text

PDF
1019

Images in this article

1021Image
on p.1021
1022Image
on p.1022
1023Image
on p.1023
1025Image
on p.1025
1025Image
on p.1025
1025Image
on p.1025
1025Image
on p.1025
1025Image
on p.1025
1025Image
on p.1025
1025Image
on p.1025
1025Image
on p.1025

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akhurst R. J., FitzPatrick D. R., Gatherer D., Lehnert S. A., Millan F. A. Transforming growth factor betas in mammalian embryogenesis. Prog Growth Factor Res. 1990;2(3):153–168. doi: 10.1016/0955-2235(90)90002-2. [DOI] [PubMed] [Google Scholar]
  2. Bader B. L., Jahn L., Franke W. W. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol. 1988 Dec;47(2):300–319. [PubMed] [Google Scholar]
  3. Cam Y., Neumann M. R., Ruch J. V. Immunolocalization of transforming growth factor beta 1 and epidermal growth factor receptor epitopes in mouse incisors and molars with a demonstration of in vitro production of transforming activity. Arch Oral Biol. 1990;35(10):813–822. doi: 10.1016/0003-9969(90)90006-v. [DOI] [PubMed] [Google Scholar]
  4. Cate R. L., Mattaliano R. J., Hession C., Tizard R., Farber N. M., Cheung A., Ninfa E. G., Frey A. Z., Gash D. J., Chow E. P. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986 Jun 6;45(5):685–698. doi: 10.1016/0092-8674(86)90783-x. [DOI] [PubMed] [Google Scholar]
  5. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  6. Connor T. B., Jr, Roberts A. B., Sporn M. B., Danielpour D., Dart L. L., Michels R. G., de Bustros S., Enger C., Kato H., Lansing M. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989 May;83(5):1661–1666. doi: 10.1172/JCI114065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. D'Souza R. N., Happonen R. P., Ritter N. M., Butler W. T. Temporal and spatial patterns of transforming growth factor-beta 1 expression in developing rat molars. Arch Oral Biol. 1990;35(12):957–965. doi: 10.1016/0003-9969(90)90015-3. [DOI] [PubMed] [Google Scholar]
  8. Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 1985 Aug 22;316(6030):701–705. doi: 10.1038/316701a0. [DOI] [PubMed] [Google Scholar]
  9. Derynck R., Lindquist P. B., Lee A., Wen D., Tamm J., Graycar J. L., Rhee L., Mason A. J., Miller D. A., Coffey R. J. A new type of transforming growth factor-beta, TGF-beta 3. EMBO J. 1988 Dec 1;7(12):3737–3743. doi: 10.1002/j.1460-2075.1988.tb03257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fitzpatrick D. R., Denhez F., Kondaiah P., Akhurst R. J. Differential expression of TGF beta isoforms in murine palatogenesis. Development. 1990 Jul;109(3):585–595. doi: 10.1242/dev.109.3.585. [DOI] [PubMed] [Google Scholar]
  11. Gatherer D., Ten Dijke P., Baird D. T., Akhurst R. J. Expression of TGF-beta isoforms during first trimester human embryogenesis. Development. 1990 Oct;110(2):445–460. doi: 10.1242/dev.110.2.445. [DOI] [PubMed] [Google Scholar]
  12. Glick A. B., Flanders K. C., Danielpour D., Yuspa S. H., Sporn M. B. Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul. 1989 Nov;1(1):87–97. doi: 10.1091/mbc.1.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Graycar J. L., Miller D. A., Arrick B. A., Lyons R. M., Moses H. L., Derynck R. Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol. 1989 Dec;3(12):1977–1986. doi: 10.1210/mend-3-12-1977. [DOI] [PubMed] [Google Scholar]
  14. Heikinheimo K., Morgan P. R., Happonen R. P., Stenman G., Virtanen I. Distribution of extracellular matrix proteins in odontogenic tumours and developing teeth. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(2):101–109. doi: 10.1007/BF02890411. [DOI] [PubMed] [Google Scholar]
  15. Heikinheimo K., Sandberg M., Happonen R. P., Virtanen I., Bosch F. X. Cytoskeletal gene expression in normal and neoplastic human odontogenic epithelia. Lab Invest. 1991 Dec;65(6):688–701. [PubMed] [Google Scholar]
  16. Heine U., Munoz E. F., Flanders K. C., Ellingsworth L. R., Lam H. Y., Thompson N. L., Roberts A. B., Sporn M. B. Role of transforming growth factor-beta in the development of the mouse embryo. J Cell Biol. 1987 Dec;105(6 Pt 2):2861–2876. doi: 10.1083/jcb.105.6.2861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jakowlew S. B., Dillard P. J., Sporn M. B., Roberts A. B. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. Mol Endocrinol. 1988 Dec;2(12):1186–1195. doi: 10.1210/mend-2-12-1186. [DOI] [PubMed] [Google Scholar]
  18. Kimchi A., Wang X. F., Weinberg R. A., Cheifetz S., Massagué J. Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. Science. 1988 Apr 8;240(4849):196–199. doi: 10.1126/science.2895499. [DOI] [PubMed] [Google Scholar]
  19. Kistler A., Galli B., Howard W. B. Comparative teratogenicity of three retinoids: the arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570. Arch Toxicol. 1990;64(1):43–48. doi: 10.1007/BF01973375. [DOI] [PubMed] [Google Scholar]
  20. Kondaiah P., Sands M. J., Smith J. M., Fields A., Roberts A. B., Sporn M. B., Melton D. A. Identification of a novel transforming growth factor-beta (TGF-beta 5) mRNA in Xenopus laevis. J Biol Chem. 1990 Jan 15;265(2):1089–1093. [PubMed] [Google Scholar]
  21. Kulozik M., Hogg A., Lankat-Buttgereit B., Krieg T. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest. 1990 Sep;86(3):917–922. doi: 10.1172/JCI114793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lehnert S. A., Akhurst R. J. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development. 1988 Oct;104(2):263–273. doi: 10.1242/dev.104.2.263. [DOI] [PubMed] [Google Scholar]
  23. Lumsden A. G. Spatial organization of the epithelium and the role of neural crest cells in the initiation of the mammalian tooth germ. Development. 1988;103 (Suppl):155–169. doi: 10.1242/dev.103.Supplement.155. [DOI] [PubMed] [Google Scholar]
  24. Lyons K. M., Jones C. M., Hogan B. L. The DVR gene family in embryonic development. Trends Genet. 1991 Nov-Dec;7(11-12):408–412. doi: 10.1016/0168-9525(91)90265-r. [DOI] [PubMed] [Google Scholar]
  25. Lyons K. M., Pelton R. W., Hogan B. L. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development. 1990 Aug;109(4):833–844. doi: 10.1242/dev.109.4.833. [DOI] [PubMed] [Google Scholar]
  26. Miettinen P. J., Heikinheimo K. Transforming growth factor-alpha (TGF-alpha) and insulin gene expression in human fetal pancreas. Development. 1992 Apr;114(4):833–840. doi: 10.1242/dev.114.4.833. [DOI] [PubMed] [Google Scholar]
  27. Millan F. A., Denhez F., Kondaiah P., Akhurst R. J. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development. 1991 Jan;111(1):131–143. doi: 10.1242/dev.111.1.131. [DOI] [PubMed] [Google Scholar]
  28. Miller D. A., Pelton R. W., Derynck R., Moses H. L. Transforming growth factor-beta. A family of growth regulatory peptides. Ann N Y Acad Sci. 1990;593:208–217. doi: 10.1111/j.1749-6632.1990.tb16113.x. [DOI] [PubMed] [Google Scholar]
  29. Munsick R. A. Human fetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancy. Am J Obstet Gynecol. 1984 Aug 15;149(8):883–887. doi: 10.1016/0002-9378(84)90609-4. [DOI] [PubMed] [Google Scholar]
  30. Okuda S., Languino L. R., Ruoslahti E., Border W. A. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest. 1990 Aug;86(2):453–462. doi: 10.1172/JCI114731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pelton R. W., Dickinson M. E., Moses H. L., Hogan B. L. In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development. 1990 Oct;110(2):609–620. doi: 10.1242/dev.110.2.609. [DOI] [PubMed] [Google Scholar]
  32. Pelton R. W., Hogan B. L., Miller D. A., Moses H. L. Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol. 1990 Oct;141(2):456–460. doi: 10.1016/0012-1606(90)90401-4. [DOI] [PubMed] [Google Scholar]
  33. Pelton R. W., Nomura S., Moses H. L., Hogan B. L. Expression of transforming growth factor beta 2 RNA during murine embryogenesis. Development. 1989 Aug;106(4):759–767. doi: 10.1242/dev.106.4.759. [DOI] [PubMed] [Google Scholar]
  34. Pelton R. W., Saxena B., Jones M., Moses H. L., Gold L. I. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991 Nov;115(4):1091–1105. doi: 10.1083/jcb.115.4.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Peltonen J., Jaakkola S., Lask G., Virtanen I., Uitto J. Fibronectin gene expression by epithelial tumor cells in basal cell carcinoma: an immunocytochemical and in situ hybridization study. J Invest Dermatol. 1988 Oct;91(4):289–293. doi: 10.1111/1523-1747.ep12475415. [DOI] [PubMed] [Google Scholar]
  36. Ponte P., Ng S. Y., Engel J., Gunning P., Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 1984 Feb 10;12(3):1687–1696. doi: 10.1093/nar/12.3.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rentrop M., Knapp B., Winter H., Schweizer J. Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions. Histochem J. 1986 May;18(5):271–276. doi: 10.1007/BF01676237. [DOI] [PubMed] [Google Scholar]
  38. Roberts A. B., Flanders K. C., Heine U. I., Jakowlew S., Kondaiah P., Kim S. J., Sporn M. B. Transforming growth factor-beta: multifunctional regulator of differentiation and development. Philos Trans R Soc Lond B Biol Sci. 1990 Mar 12;327(1239):145–154. doi: 10.1098/rstb.1990.0050. [DOI] [PubMed] [Google Scholar]
  39. Roberts V. J., Sawchenko P. E., Vale W. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology. 1991 Jun;128(6):3122–3129. doi: 10.1210/endo-128-6-3122. [DOI] [PubMed] [Google Scholar]
  40. Robey P. G., Young M. F., Flanders K. C., Roche N. S., Kondaiah P., Reddi A. H., Termine J. D., Sporn M. B., Roberts A. B. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol. 1987 Jul;105(1):457–463. doi: 10.1083/jcb.105.1.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schmid P., Cox D., Bilbe G., Maier R., McMaster G. K. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development. 1991 Jan;111(1):117–130. doi: 10.1242/dev.111.1.117. [DOI] [PubMed] [Google Scholar]
  42. Thesleff I., Hurmerinta K. Tissue interactions in tooth development. Differentiation. 1981;18(2):75–88. doi: 10.1111/j.1432-0436.1981.tb01107.x. [DOI] [PubMed] [Google Scholar]
  43. Thomas P. S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5201–5205. doi: 10.1073/pnas.77.9.5201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Vaahtokari A., Vainio S., Thesleff I. Associations between transforming growth factor beta 1 RNA expression and epithelial-mesenchymal interactions during tooth morphogenesis. Development. 1991 Nov;113(3):985–994. doi: 10.1242/dev.113.3.985. [DOI] [PubMed] [Google Scholar]
  45. Van den Eijnden-Van Raaij A. J., Koornneef I., Slager H. G., Mummery C. L., Van Zoelen E. J. Characterization of polyclonal anti-peptide antibodies specific for transforming growth factor beta 2. J Immunol Methods. 1990 Oct 4;133(1):107–118. doi: 10.1016/0022-1759(90)90324-o. [DOI] [PubMed] [Google Scholar]
  46. Weima S. M., van Rooijen M. A., Feijen A., Mummery C. L., van Zoelen E. J., de Laat S. W., van den Eijnden-van Raaij A. J. Transforming growth factor-beta and its receptor are differentially regulated in human embryonal carcinoma cells. Differentiation. 1989 Sep;41(3):245–253. doi: 10.1111/j.1432-0436.1989.tb00753.x. [DOI] [PubMed] [Google Scholar]
  47. de Martin R., Haendler B., Hofer-Warbinek R., Gaugitsch H., Wrann M., Schlüsener H., Seifert J. M., Bodmer S., Fontana A., Hofer E. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J. 1987 Dec 1;6(12):3673–3677. doi: 10.1002/j.1460-2075.1987.tb02700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. ten Dijke P., Hansen P., Iwata K. K., Pieler C., Foulkes J. G. Identification of another member of the transforming growth factor type beta gene family. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4715–4719. doi: 10.1073/pnas.85.13.4715. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES